Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Cellectis S.A. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −10 vs. Q3 2022
- Shares held
- 8.73M
- −1.57M (−15.2%) vs. Q3 2022
- Total value
- $18.3M
- −$5.27M (−22.3%) vs. Q3 2022
- New holders
- 6
- 9 more added
- Sold out
- 16
- 12 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $28.4M |
| Q1 2026 | 32 | $32.5M |
| Q4 2025 | 34 | $51.1M |
| Q3 2025 | 28 | $23.7M |
| Q2 2025 | 24 | $17.9M |
| Q1 2025 | 27 | $16.9M |
| Q4 2024 | 29 | $23.0M |
| Q3 2024 | 27 | $20.9M |
| Q2 2024 | 27 | $18.3M |
| Q1 2024 | 31 | $26.6M |
| Q4 2023 | 34 | $30.5M |
| Q3 2023 | 31 | $18.1M |
| Q2 2023 | 36 | $27.6M |
| Q1 2023 | 34 | $29.3M |
| Q4 2022 | 40 | $18.3M |
| Q3 2022 | 50 | $23.6M |
| Q2 2022 | 45 | $30.7M |
| Q1 2022 | 51 | $56.4M |
| Q4 2021 | 57 | $126.7M |
| Q3 2021 | 70 | $194.1M |
| Q2 2021 | 78 | $252.6M |
| Q1 2021 | 81 | $309.6M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Long Focus Capital Management, LLC | 2,683,633 | $5.64M | 0.93% | 00.0% | Unchanged |
| Credit Suisse AG | 1,438,255 | $3.02M | 0.00% | 00.0% | Unchanged |
| Principal Financial Group Inc | 1,334,050 | $2.80M | 0.00% | −9,417−0.7% | Reduced |
| Millennium Management LLC | 679,966 | $1.43M | 0.00% | +106,125+18.5% | Added |
| Baillie Gifford & Co | 599,896 | $1.26M | 0.00% | −188,941−24.0% | Reduced |
| Capital International Investors | 448,804 | $942.5K | 0.00% | 00.0% | Unchanged |
| Capital World Investors | 250,000 | $525.0K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 227,112 | $476.9K | 0.00% | −51,215−18.4% | Reduced |
| Macquarie Group Ltd | 226,875 | $476.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 211,467 | $449.6K | 0.00% | −132,427−38.5% | Reduced |
| KBC Group NV | 163,447 | $343.0K | 0.00% | 00.0% | Unchanged |
| Oppenheimer & Co Inc | 75,052 | $157.6K | 0.00% | −16,911−18.4% | Reduced |
| Morgan Stanley | 74,141 | $155.7K | 0.00% | −1,812−2.4% | Reduced |
| Citadel Advisors LLC | 58,207 | $122.2K | 0.00% | +45,849+371.0% | Added |
| Susquehanna International Group, LLP | 58,087 | $122.0K | 0.00% | +58,087 | New |
| Envestnet Asset Management Inc | 57,447 | $120.6K | 0.00% | +11,928+26.2% | Added |
| Tower Research Capital LLC (TRC) | 26,362 | $56.0K | 0.00% | +19,300+273.3% | Added |
| Ergoteles LLC | 19,365 | $40.7K | 0.00% | +19,365 | New |
| Goldman Sachs Group Inc | 18,208 | $38.2K | 0.00% | +18,208 | New |
| Wells Fargo & Company | 16,979 | $35.7K | 0.00% | −250−1.5% | Reduced |
| Vontobel Holding Ltd. | 14,000 | $29.4K | 0.00% | 00.0% | Unchanged |
| Old Mission Capital LLC | 11,752 | $24.7K | 0.00% | +11,752 | New |
| Geode Capital Management, LLC | 10,776 | $22.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 7,119 | $14.9K | 0.00% | −11,944−62.7% | Reduced |
| Advisor Group Holdings, Inc. | 6,237 | $13.0K | 0.00% | −166−2.6% | Reduced |
| UBS Group AG | 5,447 | $11.4K | 0.00% | +1,540+39.4% | Added |
| National Bank of Canada | 3,600 | $7.45K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 2,755 | $5.79K | 0.00% | −278,946−99.0% | Reduced |
| Assetmark, Inc | 1,520 | $3.19K | 0.00% | +380+33.3% | Added |
| JPMorgan Chase & Co | 1,598 | $3.00K | 0.00% | +248+18.4% | Added |
| Money Concepts Capital Corp | 515 | $1.08K | 0.00% | +515 | New |
| TD Waterhouse Canada Inc. | 360 | $806 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 263 | $552 | 0.00% | +10+4.0% | Added |
| BNP Paribas Arbitrage, SA | 166 | $349 | 0.00% | +166 | New |
| Parkside Financial Bank & Trust | 147 | $309 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 28 | $59 | 0.00% | −622−95.7% | Reduced |
| US Bancorp | 10 | $21 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 9 | $19 | 0.00% | 00.0% | Unchanged |
| Sofos Investments, Inc. | 2 | $2 | 0.00% | −6−75.0% | Reduced |
| Royal Bank of Canada | 65 | $0 | 0.00% | +9+16.1% | Added |
| State Street Corp | 0 | $0 | 0.00% | −262,368−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −210,659−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −169,802−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −108,744−100.0% | Sold out |
| Kettle Hill Capital Management, LLC | 0 | $0 | 0.00% | −104,596−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −85,864−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −74,532−100.0% | Sold out |
| WS Management LLLP | 0 | $0 | 0.00% | −50,907−100.0% | Sold out |
| Baird Financial Group, Inc. | 0 | $0 | 0.00% | −32,640−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −18,352−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −14,900−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −13,303−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −10,977−100.0% | Sold out |
| Princeton Capital Management LLC | 0 | $0 | 0.00% | −10,594−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −168−100.0% | Sold out |